Overview
- The FDA cleared updated 2025–26 vaccines from Pfizer, Moderna and Novavax only for people 65 and older or younger patients with at least one qualifying medical condition.
- CVS is requiring prescriptions in 13 states and Washington, D.C., and is not offering the shots in Massachusetts, Nevada and New Mexico, citing the current regulatory environment.
- Walgreens says it will offer vaccinations where legally permitted, with many states requiring a clinician’s prescription until CDC advisory recommendations are issued.
- In numerous states, pharmacist authority depends on ACIP guidance, insurers are waiting for the Sept. 18–19 ACIP meeting before finalizing coverage, and off‑label prescriptions may face practical and payment hurdles.
- Illinois is exploring direct purchases from manufacturers, and a coalition led by Massachusetts is discussing coordinated pediatric supply plans should federal guidance restrict wider access.